JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ACLX
3826
CALL
DELISTED
Arcellx
ACLX
| $1.5M | ﹤0.01% |
+27,100
| New | +$1.47M |
2024 Q2
0 quarters
|
|
3827
Cadeler
CDLR
$2.14B
| $1.49M | ﹤0.01% |
59,688
-21,763
| -27% | -$459K |
2023 Q4
2 quarters
|
|
3828
Philips
PHG
$23.4B
| $1.49M | ﹤0.01% |
64,005
-23,065
| -26% | -$518K |
2013 Q2
44 quarters
|
|
3829
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.46B
| $1.49M | ﹤0.01% |
68,205
-14,862
| -18% | -$322K |
2023 Q2
4 quarters
|
|
3830
James River Group Holdings
JRVR
$161M
| $1.49M | ﹤0.01% |
192,358
+49,687
| +35% | +$408K |
2015 Q4
34 quarters
|
|
|
EXAS
3831
PUT
DELISTED
Exact Sciences
EXAS
| $1.48M | ﹤0.01% |
35,100
-38,300
| -52% | -$2.11M |
2024 Q1
1 quarter
|
|
3832
PUT
Community Health Systems
CYH
$384M
| $1.48M | ﹤0.01% |
+439,400
| New | +$1.48M |
2024 Q2
0 quarters
|
|
3833
Kura Sushi USA
KRUS
$505M
| $1.47M | ﹤0.01% |
23,379
-4,352
| -16% | -$439K |
2019 Q3
19 quarters
|
|
|
SAVE
3834
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.47M | ﹤0.01% |
+401,500
| New | +$1.55M |
2024 Q2
0 quarters
|
|
3835
PUT
Chemours
CC
$2.06B
| $1.47M | ﹤0.01% |
65,000
| – | – |
2023 Q3
3 quarters
|
|
3836
PUT
Stryker
SYK
$106B
| $1.46M | ﹤0.01% |
+4,300
| New | +$1.46M |
2024 Q2
0 quarters
|
|
3837
Lindsay Corp
LNN
$1.16B
| $1.46M | ﹤0.01% |
11,841
-11,557
| -49% | -$1.35M |
2013 Q2
44 quarters
|
|
3838
Unity Bancorp
UNTY
$556M
| $1.45M | ﹤0.01% |
49,198
-6,884
| -12% | -$186K |
2017 Q4
26 quarters
|
|
3839
CALL
DraftKings
DKNG
$9.23B
| $1.45M | ﹤0.01% |
38,100
-63,800
| -63% | -$2.65M |
2023 Q4
2 quarters
|
|
|
NPKI
3840
NPK International
NPKI
$1B
| $1.45M | ﹤0.01% |
174,921
-44,905
| -20% | -$346K |
2016 Q4
30 quarters
|
|
|
HIBB
3841
PUT
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.45M | ﹤0.01% |
+16,600
| New | +$1.37M |
2024 Q2
0 quarters
|
|
3842
PUT
Johnson & Johnson
JNJ
$617B
| $1.45M | ﹤0.01% |
9,900
-60,100
| -86% | -$8.94M |
2014 Q2
40 quarters
|
|
3843
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $1.45M | ﹤0.01% |
32,289
-25,374
| -44% | -$1.14M |
2016 Q4
30 quarters
|
|
3844
ARK Next Generation Technology ETF
ARKW
$1.95B
| $1.45M | ﹤0.01% |
18,528
+9,749
| +111% | +$752K |
2020 Q1
17 quarters
|
|
|
GOOD
3845
Gladstone Commercial Corp
GOOD
$626M
| $1.44M | ﹤0.01% |
101,225
-23,822
| -19% | -$332K |
2013 Q3
43 quarters
|
|
3846
iShares US Tech Independence Focused ETF
IETC
$740M
| $1.44M | ﹤0.01% |
19,142
+26
| +0.1% | +$1.83K |
2022 Q4
6 quarters
|
|
3847
CALL
Ultragenyx Pharmaceutical
RARE
$1.5B
| $1.44M | ﹤0.01% |
35,000
| – | – |
2024 Q1
1 quarter
|
|
|
3848
PUT
Ultragenyx Pharmaceutical
RARE
$1.5B
| $1.44M | ﹤0.01% |
35,000
| – | – |
2024 Q1
1 quarter
|
|
3849
Univest Financial
UVSP
$1.15B
| $1.44M | ﹤0.01% |
62,986
-31,799
| -34% | -$672K |
2015 Q4
34 quarters
|
|
3850
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$301M
| $1.44M | ﹤0.01% |
+65,733
| New | +$1.44M |
2024 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.